Feature | March 26, 2013

SNMMI Launches Online Dose Optimization Resource

March 26, 2013 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) launched a new online resource for imaging professionals, referring physicians and the public on dose optimization for nuclear medicine and molecular imaging procedures. The information is designed to help ensure patients receive the smallest possible amount of radiopharmaceutical that will provide the appropriate diagnostic information.

“Advancing a better understanding of radiation dose and risk and promoting dose optimization in nuclear medicine and molecular imaging is a top priority for SNMMI,” said Frederic H. Fahey, DSC, SNMMI president. “The online resource is a key component of our dose optimization initiative, as it compiles important information in an organized fashion in one central location.”

The online resource includes SNMMI journal articles, abstracts, educational offerings, news articles, presentations and links to useful websites, as well as other materials. The resource will be promoted to SNMMI members through various communication channels, promoted through social media and shared with referring physician and patient groups.

In June 2012, SNMMI started its dose optimization initiative by issuing a position statement, saying that radiation dose for all nuclear medicine and molecular imaging procedures should be optimized by ensuring that the patient receives the minimum radiation dose necessary to provide useful diagnostic information. The position statement recognizes that the use of low levels of radiation in nuclear medicine procedures carries some possible risk. However, if an appropriate procedure — one that can provide the physician with clinical information essential to the patient’s treatment — is not performed when necessary due to fear of radiation, it can be detrimental to the patient.

Dose optimization has become a part of SNMMI’s communications, outreach, advocacy and education efforts. This integrated approach helps to provide information and guidance on dose optimization to imaging professionals, referring physicians, policy makers and the public. In addition to these activities, SNMMI continues to actively participate in the Image Gently and Image Wisely campaigns. 

“It is our firm belief that the ‘right test with the right dose should be given to the right patient at the right time,’” said Fahey. “We hope that this online resource will provide professionals with tools they can use to implement this into clinical practice and educate the public about optimal dosing for nuclear medicine and molecular imaging procedures.”

For more information: www.snmmi.org/dose

Related Content

Imaging agent helps predict success of lung cancer therapy
News | Oncology Diagnostics | March 08, 2018
March 8, 2018 – Doctors contemplating the best therapy for...
The yellow in the anterolateral entorhinal cortex of the young brain indicates significant activity, something that is absent in the older brain.

This figure shows two different brains that are aligned to a common template space for comparison. The yellow in the anterolateral entorhinal cortex of the young brain indicates significant activity, something that is absent in the older brain. CREDIT: Zachariah Reagh

News | Nuclear Imaging | March 08, 2018
As we get older, it's not uncommon to experience "senior moments," in which we forget where we parked our car or call...
Axumin PET Agent Added to NCCN Guidelines for Suspected Recurrent Prostate Cancer
News | PET Imaging | February 21, 2018
Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the National Comprehensive...
Radiography Education Enrollment Shows Marginal Rise in 2017
News | Radiology Business | February 15, 2018
Directors of radiography educational programs report the number of enrolled students increased slightly in 2017, while...
Mirion Technologies Introduces Instadose Radiation Dosimeter
Technology | Radiation Dose Management | February 08, 2018
The Instadose + dosimeter, the latest by Mirion Technologies, transforms...
A Tc99m SPECT cardiac exam showing myocardial perfusion in the heart.

Technetium-99m is primarily used for the detection of cancer and to assess perfusion defects in the heart caused by heart attacks or other conditions.

Feature | Radiopharmaceuticals and Tracers | February 08, 2018 | Dave Fornell
February 8, 2018 — The U.S.
PSMA PET-CT Clearly Differentiates Prostate Cancer from Benign Tissue

68Ga-PSMA PET/CT images showing multifocal PCA in peripheral zone with GS of 5 1 5 5 10. (A and C) Axial PET images. (B and D) Fused PET/CT images. SUVmax of lesion in B was 84.3 and that of lesion in D was 5.7. IRS was 3, and 80% of cells were stained. Credit: Senior author V Prasad, Charité Universitätsmedizin Berlin, Berlin, Germany.

News | PET-CT | February 05, 2018
February 5, 2018 — Using nuclear medicine...
FDA Releases New Guidance on Children's X-ray Exams
Feature | Pediatric Imaging | January 26, 2018
Most people have had an X-ray taken at some time during their lives — perhaps checking for a possible broken bone or...
Brain-scan guided emergency stroke treatment can save more lives
News | Neuro Imaging | January 25, 2018
January 25, 2018 – Advances in brain imagin...
PET Tracer Measures Damage From Multiple Sclerosis in Mouse Models
News | PET Imaging | January 24, 2018
January 24, 2018 — The loss or damage of myelin, a cellular sheath that surrounds and insulates nerves, is the hallma
Overlay Init